NOBGF yields 2000000.00% · JNJ yields 2.13%● Live data
📍 NOBGF pulled ahead of the other in Year 1
Combined, NOBGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NOBGF + JNJ for your $10,000?
Noble Group Limited is in the process of liquidation. Previously, the company was operated as an independent energy products and industrial raw materials supply chain manager. Its Energy segment was engaged in trading energy coal and the provision of supply chain and risk management services in bituminous and sub-bituminous energy coal, as well as in seaborne LNG. The company's Metals, Minerals and Ores segment was involved in trading and providing supply chain management services in copper, zinc, lead, nickel, and other raw materials, as well as aluminum, alumina, and bauxite. The company was also engaged in trading and providing risk management and logistics services for the steel complex in iron ore, metallurgical coal, metallurgical coke, specialty ores and alloys, and industrial metals and minerals, as well as offered ocean transport in the dry bulk segment, long term freight solutions, and freight market guidance. The company was founded in 1987 and is headquartered in London, the United Kingdom.
Full NOBGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.